தரமான தகவல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தரமான தகவல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தரமான தகவல் Today - Breaking & Trending Today

K Line: Brief report of the the year ended March 31, 2021 | Hellenic Shipping News Worldwide


K Line: Brief report of the the year ended March 31, 2021
1. Qualitative Information and Financial Statement
(1) Qualitative Information about the Consolidated Operating Result
1) Summary of Consolidated Operating Results for FY2020
Due to significant business performance improvement of OCEAN NETWORK EXPRESS PTE. LTD. (hereinafter referred to as “ONE”), the company recorded 118.165 billion yen of equity in earnings of subsidiaries for the fiscal year 2020. Within the recorded equity in earnings of subsidiaries, “ONE” accounted for 119.271 billion yen in consolidated cumulative fourth quarter, and 67.325 billion yen in the fourth quarter alone.
(i) Dry Bulk Segment
Dry Bulk Business
In the Cape-size sector, market rates fell steeply early in the current fiscal year as a result of the combined effects of stagnant economic activity due to the spread of COVID-19 and a decrease in shipments due to unfavorable weather conditions in production location ....

United States , Mipv Bidco , Macquarie Infrastructure , Kawasaki Kisen Kaisha Ltd , Energyep Business , Energy Resource Transport Segment , Qualitative Information , Consolidated Operating , Consolidated Operating Results , Dry Bulk , Forward Freight Agreement , Dry Bulk Segment , Energy Resource Transport , Thermal Coal Carrier , Floating Production , Product Logistics , North America , Real Assets , Asia North America , Product Logistics Segment , Full Report , Kawasaki Kisen Kaisha , ஒன்றுபட்டது மாநிலங்களில் , மக்வரீ உள்கட்டமைப்பு , ஆற்றல் வள போக்குவரத்து பிரிவு , தரமான தகவல் ,

Global Multiple Myeloma Treatment Market (2021 to 2026) - Key Drivers, Challenges and Opportunities


Press release content from Business Wire. The AP news staff was not involved in its creation.
Global Multiple Myeloma Treatment Market (2021 to 2026) - Key Drivers, Challenges and Opportunities - ResearchAndMarkets.com
May 11, 2021 GMT
DUBLIN (BUSINESS WIRE) May 11, 2021
This report offers strategic insights into the overall multiple myeloma treatment market along with the market size and estimates for the duration 2019 to 2029. The said research study cover in-depth analysis of multiple myeloma market segments based on type and different geographies further segmented by countries. According to myeloma UK, in myeloma, plasma cells become abnormal, multiply uncontrollably and release only one type of antibody known as paraprotein, which has no useful function. It is often through the measurement of this paraprotein that myeloma is diagnosed and monitored. ....

United States , United Kingdom , Saudi Arabia , South Africa , Bristol Myers Squibb , Laura Wood , Janssen Biotech Inc , Celgene Corporation , Bristol Myers Squibb Company , Kesios Therapeutics , Merck Kga , Abbvie Inc , Takeda Pharmaceutical Industries Ltd , Genzyme Corporation , Office Hours Call , Genentech Inc , Millennium Pharmaceuticals , Company Profiles , Millennium Pharmaceuticals Inc , E St Office Hours Call , Amgen Inc , Merck Kgaa , University Of Arkansas , Myeloma Treatment Market Size , Market Share , Application Analysis ,

Worldwide Neurological Diseases Treatment Industry to 2029 - Featuring Novartis, GlaxoSmithKline and Bayer Among Others


Share this article
Share this article
ResearchAndMarkets.com s offering.
This report offers strategic insights into the overall neurological diseases treatment market along with the market size and estimates for the duration 2019 to 2029. The said research study cover in-depth analysis of neurological treatment market segments based on type of drugs, diseases and different geographies further segmented by countries.
For the purpose of this study, the global neurological diseases treatment market is segmented on the basis of drug type into anticholinergic, antiepileptic, antipsychotic, hypnotic & sedative, analgesics, antihypertensive, anticoagulants, and others. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year. ....

United States , South Africa , Saudi Arabia , Boehringer Ingelheim Gmb , Rivaroxaban Xarelto , Avonex Biocard , Asia Pacific , Bayer Janssen , Laura Wood , Cellular Therapies Inc , Neuroderm Ltd , Merck Co , Janssen Research Development , Zogenix Inc , Biogen Inc , Teva Pharmaceutical Industries Ltd , Alkermes Inc , Abbvie Inc , Nono Inc , Sunovion Pharmaceuticals Inc , Roche Ltd , Bayer Ag , Avanir Pharmaceuticals , Office Hours Call , P Gw Research Ltd , World Health Organization ,